Ligand Pharmaceuticals
LGND
$70.46
Share price
-0.16%
Change (1 day)
-8.16%
Change (1 year)
Ligand Pharmaceuticals (LGND) - Net assets
Net assets on the balance sheet as of December 2023 : $0.70 B
According to Ligand Pharmaceuticals's latest financial reports the company has $0.70 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Ligand Pharmaceuticals - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.70 B | 17.31% |
| 2022-12-31 | $0.59 B | -27.24% |
| 2021-12-31 | $0.82 B | 15.73% |
| 2020-12-31 | $0.70 B | -7.52% |
| 2019-12-31 | $0.76 B | 36.78% |
| 2018-12-31 | $0.56 B | 33.98% |
| 2017-12-31 | $0.41 B | 12.89% |
| 2016-12-31 | $0.37 B | 33.93% |
| 2015-12-31 | $0.27 B | 1034.51% |
| 2014-12-31 | $24.4 M | -50.8% |
| 2013-12-31 | $49.61 M | 87.32% |
| 2012-12-31 | $26.48 M | 223.58% |
| 2011-12-31 | $8.18 M | -268.8% |
| 2010-12-31 | $-4.85 M | -229.51% |
| 2009-12-31 | $3.74 M | -136.12% |
| 2008-12-31 | $-10.37 M | -135.6% |
| 2007-12-31 | $29.11 M | 6.45% |
| 2006-12-31 | $27.35 M | -124.77% |
| 2005-12-31 | $-0.12 B | 46.61% |
| 2004-12-31 | $-75.32 M | 100.56% |
| 2003-12-31 | $-37.56 M | -150.74% |
| 2002-12-31 | $74.01 M | -227.89% |
| 2001-12-31 | $-57.88 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $68.77 B | 9,712.06% | 🇺🇸 USA |
 Pfizer PFE | $89.28 B | 12,638.81% | 🇺🇸 USA |
 Eli Lilly LLY | $10.86 B | 1,449.94% | 🇺🇸 USA |
 Amgen AMGN | $6.23 B | 789.13% | 🇺🇸 USA |
 Baxter BAX | $8.46 B | 1,108.14% | 🇺🇸 USA |
 Merck MRK | $37.63 B | 5,269.43% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $16.54 B | 2,260.92% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $16.28 B | 2,223.83% | 🇬🇧 UK |
 Spectrum Pharmaceuticals
SPPI | $26.8 M | -96.18% | 🇺🇸 USA |